Search - tctmd.com

Displaying 701 - 720 of 740

Sort: Relevancy | Date

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Leah Lawrence

January 05, 2012

Presentation TCT 2012

Clinical Evaluation of the IN.PACT Drug-eluting Balloon for Treatment of Femoro-popliteal Arterial Disease: Twelve Month Results from a Multicenter Italian Registry

Presenter: Antonio Micari, Angelo Cioppa, Giuseppe Vadal?, Fausto Castriota, Armando Liso, Alfredo Marchese, Alberto Cremonesi, Paolo Rubino, Giancarlo Biamino

January 03, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Daily News

Cutting Balloon Helps Treat Resistant Pulmonary Artery Stenosis

Jason Kahn

November 03, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Daily News

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Jason Kahn

August 08, 2011

News Daily News

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

L.A. McKeown

August 02, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

Advertisement

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Clinical Evaluation of the IN.PACT Drug-eluting Balloon for Treatment of Femoro-popliteal Arterial Disease: Twelve Month Results from a Multicenter Italian Registry

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Some New-Generation Stents Prone to Longitudinal Distortion

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Cutting Balloon Helps Treat Resistant Pulmonary Artery Stenosis

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

First DES for Above-the-Knee Vascular Disease on the Horizon

IVUS Guidance of DES Implantation Improves Outcomes

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content